期刊文献+

超声分子成像的研究进展 被引量:2

Advance in Ultrasound Molecular Imaging
原文传递
导出
摘要 超声成像无创、无放射性、低成本、实时成像的优点,使其成为目前世界上应用最广的成像手段之一。特别是超声造影剂引入之后,超声成像的图像分辨率和灵敏度得到了大大提高,使超声成像在临床上得到了进一步应用。近年来,随着分子生物学和超声成像技术的不断发展,人们提出了"超声分子成像"的概念。它是一项结合了分子靶向造影剂和超声影像技术的能在分子水平下观察病理变化的新兴技术,目前这一技术还处于研究初期阶段。但大量临床前的研究成果已表明超声分子成像在诊断血管生成、炎症和血栓三种疾病具有很大应用前景。本文主要综述了目前常用超声造影剂的种类以及超声分子成像技术的研究现状,并对该技术进行了讨论和展望。 Ultrasound imaging is one of the most widely used imaging techniques in the world due to its non-invasive, non-radioactive, cheap and real-time imaging features. The introduction of ultrasound contrast agents improves the sensitivity and resolution of ultrasonic images, further expanding the application of ultrasound imaging in clinical practice. In the recent years, the concept of ultrasound molecular imaging was put forward with the development of molecular biology and ultrasound imaging technology. This new technology, which combines ultrasound technology with molecule-targeted contrast agents for assessing the biological processes at the molecular level, is still in its infancy. However, many preclinical studies have showed that ultrasound molecular imaging showed prospect in assessing angiogenesis, inflammation, and thrombus. This review outlines the recent progress in ultrasound contrast agents and the potential applications of ultrasound molecular imaging in the clinical practice. The existing problems and future directions of ultrasound molecular imaging technology were also proposed at the end of the paper.
出处 《现代生物医学进展》 CAS 2014年第27期5372-5376,共5页 Progress in Modern Biomedicine
基金 国家自然科学基金项目(81101094)
关键词 超声分子成像 造影剂 炎症 血栓 血管生成 Ultrasound molecular imaging Contrast agent Inflammation Thrombus Angiogenesis
  • 引文网络
  • 相关文献

参考文献30

  • 1Schutt EG, Klein DH, Mattrey RM, et al. Injectable microbubbles as contrast agents for diagnostic ultrasound imaging: The key role ofperfluorochemieals [J]. Angew Chem lnt Ed, 2003, 42:3218-3235.
  • 2Cosgrove D. Ultrasound contrast agents: An overview [J]. European Journal of Radiology, 2006, 60:324-330.
  • 3Lcncioni R. Impact of European federation of societies for ultrasound in medicine and biology (EFSUMB) guidelines on the use of contrast agents in liver ultrasound [J]. Eur Radiol, 2006, 16:1610-1613.
  • 4Slyer AM, Ingrid SG, Rune H. Intravascular Targets for Molecular Contrast-Enhanced [J]. Ultrasound Imaging Int J Mol Sci, 2012, 13: 6679-6697.
  • 5余进洪,王志刚.超声分子成像的机制及研究现状[J].中国医学影像技术,2009,25(4):709-711. 被引量:5
  • 6Ryan G, Paul AD. Advances in Molecular Imaging with Ultrasound [J]. Mol Imaging. 2010, 9(3): 117-127.
  • 7Hernot S, LKlibanov A. Microbubbles in Ultrasound-triggered Drug and Gene Delivery [J]. Advanced Drug Delivery Reviews, 2008, 60: 1153-1166.
  • 8EI-Sherif DM, Wheatley MA. Development of a Novel Method for Synthesis of a Polymeric Ultrasound Contrast Agent [J]. J of Biomedical Materials Research Part A, 2003, 66A(2): 347-355.
  • 9Ke HT, Wang JR, Dai ZF, et al. Gold-Nanoshelled Microcapsules: A Theranostic Agent for Ultrasound Contrast Imaging and Photothermal Therapy [J]. Angew Chem Int Ed, 2011, 50:1-6.
  • 10Li P, Zheng Y, Ran H, et al. Ultrasound triggered drug release from 10-hydroxycamptothecin-loaded phospholipid microbubbles for targeted tumor therapy in mice [J]. Journal of control release, 2012, 162:349-354.

二级参考文献28

共引文献12

同被引文献14

引证文献2

二级引证文献7

相关主题

;
使用帮助 返回顶部